GlassScriptPhysician profile
Gopal Reddy Gade
NPI 1831167899
$1,811.61
in general payments reported to CMS, 2019-2025
15 companies · $675 in 2025
The $675 reported for 2025 was more than what 86% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $68.84 · 2020: $120 · 2022: $46.71 · 2023: $183 · 2024: $718 · 2025: $675.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,576.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,575.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $649.72 | 2024-2025 | |
| Mayne Pharma Commercial LLC | $647.49 | 2023-2025 | |
| Lupin INC. | $106.45 | 2019-2020 | |
| Hologic Sales and Service, LLC | $81.40 | 2019-2025 | Fetal Fibronectin Enzyme Immunoassay, Aptima, Thinprep 2000 Processor |
| Organon LLC | $75.17 | 2022-2023 | Nexplanon |
| Sage Therapeutics, LLC | $73.22 | 2025 | Zurzuvae |
| Pfizer INC. | $33.63 | 2024 | |
| Therapeuticsmd, INC. | $27.80 | 2020-2022 | |
| Pharmacosmos Therapeutics INC. | $24.28 | 2025 | Monoferric |
| Coopersurgical, INC. | $18.26 | 2019 | |
| Abbvie INC. | $15.43 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.27 | 2019 | |
| Ethicon US, LLC | $15.17 | 2025 | Stratafix, Dermabond, Vistaseal |
| Supernus Pharmaceuticals, INC. | $15.03 | 2025 | Qelbree |
| Becton, Dickinson and Company | $13.29 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gopal Gade listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.